Nanomechanical sensor for rapid and ultrasensitive detection of tumor markers in serum using nanobody

Depeng Rao,Kainan Mei,Tianhao Yan,Yu Wang,Wenjie Wu,Ye Chen,Jianye Wang,Qingchuan Zhang,Shangquan Wu

DOI: https://doi.org/10.1007/s12274-021-3588-4

IF: 9.9

2021-06-29

Nano Research

Abstract:<p class="a-plus-plus">Early cancer diagnosis requires ultrasensitive detection of tumor markers in blood. To this end, we develop a novel microcantilever immunosensor using nanobodies (Nbs) as receptors. As the smallest antibody (Ab) entity comprising an intact antigen-binding site, Nbs achieve dense receptor layers and short distances between antigen-binding regions and sensor surfaces, which significantly elevate the generation and transmission of surface stress. Owing to the inherent thiol group at the C-terminus, Nbs are covalently immobilized on microcantilever surfaces in directed orientation via one-step reaction, which further enhances the stress generation. For microcantilever-based nanomechanical sensor, these advantages dramatically increase the sensor sensitivity. Thus, Nb-functionalized microcantilevers can detect picomolar concentrations of tumor markers with three orders of magnitude higher sensitivity, when compared with conventional Ab-functionalized microcantilevers. This proof-of-concept study demonstrates an ultrasensitive, label-free, rapid, and low-cost method for tumor marker detection. Moreover, interestingly, we find Nb inactivation on sensor interfaces when using macromolecule blocking reagents. The adsorption-induced inactivation is presumably caused by the change of interfacial properties, due to binding site occlusion upon complex coimmobilization formations. Our findings are generalized to any coimmobilization methodology for Nbs and, thus, for the construction of high-performance immuno-surfaces.</p>

materials science, multidisciplinary,chemistry, physical,physics, applied,nanoscience & nanotechnology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to rapidly and ultrasensitively detect tumor markers in serum for the early diagnosis of cancer. Specifically, the researchers have developed a micro - cantilever immunosensor based on Nanobodies (Nbs) aiming to improve the sensitivity of detecting tumor markers. Nanobodies are currently the smallest antibody units, with complete antigen - binding sites, which can achieve a high - density receptor layer and a short distance between the antigen - binding region and the sensor surface, thereby significantly enhancing the generation and transfer efficiency of surface stress. Through this method, the researchers hope to achieve the detection of picomolar concentrations of tumor markers, and compared with the traditional antibody - functionalized micro - cantilevers, its sensitivity is increased by three orders of magnitude. In addition, this study also explored the inactivation phenomenon of Nanobodies on the sensor interface when using macromolecular blockers, which is of great significance for constructing high - performance immune surfaces.